Studying gefapixant for cough in kidney or bladder cancer
Part of Lungs & breathing clinical trials.
This study tests a medicine called gefapixant to see if it helps reduce chronic coughing in people with kidney or bladder cancer. You may qualify if your cough persists despite treatment and you have little to no smoking history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney or bladder cancer (diagnosed at least 8 weeks ago).
- Your cough continues even after treatment for common causes like asthma, acid reflux, or postnasal drip.
- You either never smoked, or you smoked but no more than 20 pack-years (for example, 1 pack a day for 20 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests whether gefapixant changes brain activity related to cough in people with chronic cough that hasn’t improved with usual treatments. It may help researchers understand why chronic cough happens and how to better treat it.
This study tests two treatments—nerve blockers and a cough control therapy—for people with chronic cough that hasn't improved with standard treatments or has no clear cause. The goal is to find better ways to reduce coughing and improve quality of life.
This study aims to better understand different types of chronic cough by using a new questionnaire. If you have had a cough for at least 8 weeks and do not smoke, you may be able to help.
This study looks at how certain nerve receptors (called P2X3) and a molecule called ATP might be linked to inflammation in the airways of people with chronic cough. It compares chronic cough patients to healthy non-smokers to better understand the cause of cough and find new treatment targets.
This study looks at changes in the lower airways of people with a long-lasting cough that hasn't improved with treatment. It aims to understand why some coughs persist, which may lead to better treatments.
This study tests whether a 4-week online therapy focusing on breathing techniques can help adults manage chronic cough that has lasted 8+ weeks. The therapy teaches acceptance and coping skills to reduce cough severity and improve quality of life.
Hear when a new Chronic Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.